Table 1 Baseline characteristics
Total (n = 1388) | Male (n = 947) | Female (n = 441) | p | |
|---|---|---|---|---|
Age (years) | 81 [75–84] | 80 [75–83] | 82 [77–85] | < 0.001 |
BMI (kg/m2) | 26.4 [24.1–29] | 26.3 [24.3–28.7] | 26.4 [23.5–29.4] | 0.34 |
CV risk factors, no. (%) | ||||
Diabetes | 465 (33.5) | 323 (34.1) | 142 (32.2) | 0.47 |
Hypertension | 1170 (84.4) | 782 (82.7) | 388 (88.1) | 0.011 |
Hyperlipidemia | 775 (55.9) | 536 (56.7) | 239 (54.2) | 0.39 |
Current smoker | 387 (30.1) | 335 (35.4) | 52 (11.8) | < 0.001 |
Medical history, no. (%) | ||||
MI | 445 (32.1) | 351 (37.1) | 94 (21.3) | < 0.001 |
PCI | 397 (28.6) | 300 (31.7) | 97 (22) | < 0.001 |
CABG | 146 (10.5) | 132 (14) | 14 (3.2) | < 0.001 |
PAD | 286 (20.6) | 221 (23.4) | 65 (14.7) | < 0.001 |
Clinical presentation | ||||
STEMI (%) | 284 (20.5) | 185 (19.5) | 99 (22.4) | 0.21 |
Killip class > I, no. (%) | 232 (16.8) | 137 (14.6) | 95 (21.7) | 0.001 |
Laboratory data (at inclusion) | ||||
White blood cells, (u/μl) | 7.8 [6.6–9.6] | 6.7 [5.7–7.8] | 6.6 [5.5–7.8] | 0.58 |
Hemoglobin, (g/dl) | 12.7 [11.3–14] | 13.1 [11.6–14.3] | 12 [10.7–13] | < 0.001 |
Creatinine clearance, (ml/min) | 53 [39–67.3] | 55 [41.4–68.3] | 47.5 [34.5–61.3] | < 0.001 |
Low-density lipoprotein (mg/dl) | 93.2 [68.6–125] | 90 [66–119] | 107.6 [76-137] | < 0.001 |
Other data | ||||
LVEF (%) | 54 [44–60] | 54 [44–60] | 54 [44–60] | 0.35 |
Invasive strategy, no (%) | 1283 (92.4) | 899 (95.1) | 384 (86.4) | < 0.001 |
Multivessel disease, no (%) | 880 (70.1) | 645 (73.4) | 235 (62) | < 0.001 |
Coronary revascularization, no (%) | 1238 (89.2) | 870 (92) | 368 (83.4) | < 0.001 |